Junya Takada1, Norihiro Honda2, Hisanao Hazama1, Kunio Awazu3. 1. Graduate School of Engineering, Osaka University. 2. Institute for Academic Initiatives, Osaka University. 3. Graduate School of Engineering, Osaka University ; Graduate School of Frontier Biosciences, Osaka University ; The Center for Advanced Medical Engineering and Informatics, Osaka University.
Abstract
BACKGROUND AND OBJECTIVE: Laser vaporization of the prostate is considered to be a promising treatment for benign prostatic hyperplasia (BPH), and efficiency of vaporization and hemostasis are both important parameters for such treatment. In this study, we used a high-power laser diode with a wavelength of 980 nm to obtain high vaporization efficiency with good hemostasis. The objective of this study is to evaluate the efficacy of laser vaporization for treatment of BPH in ex vivo experiments using a 300-W high-power laser diode with a wavelength of 980 nm quantitatively. MATERIALS AND METHODS: An ex vivo experimental setup simulating clinical treatment situation was constructed. Bovine prostate tissue was used as a sample. The power setting was 100, 150, 200, 250, or 300 W, and the irradiation time was 0.5, 1, or 2 s. After laser irradiation, vaporized and coagulated depths were measured. RESULTS: The vaporized depth increased with the laser power and irradiation time, and the results confirmed that the high-power laser diode could efficiently vaporize the prostate tissue. Coagulated depth increased as the laser power became higher. CONCLUSIONS: Laser vaporization of prostate tissue using a high-power laser diode with a wavelength of 980 nm represents a promising treatment for BPH; this method exhibits high vaporization efficiency and good hemostasis. However, operators must be aware of the risk of postoperative perforation of the prostatic capsule caused by coagulation of deep regions that cannot be visualized by endoscopic observation.
BACKGROUND AND OBJECTIVE: Laser vaporization of the prostate is considered to be a promising treatment for benign prostatic hyperplasia (BPH), and efficiency of vaporization and hemostasis are both important parameters for such treatment. In this study, we used a high-power laser diode with a wavelength of 980 nm to obtain high vaporization efficiency with good hemostasis. The objective of this study is to evaluate the efficacy of laser vaporization for treatment of BPH in ex vivo experiments using a 300-W high-power laser diode with a wavelength of 980 nm quantitatively. MATERIALS AND METHODS: An ex vivo experimental setup simulating clinical treatment situation was constructed. Bovine prostate tissue was used as a sample. The power setting was 100, 150, 200, 250, or 300 W, and the irradiation time was 0.5, 1, or 2 s. After laser irradiation, vaporized and coagulated depths were measured. RESULTS: The vaporized depth increased with the laser power and irradiation time, and the results confirmed that the high-power laser diode could efficiently vaporize the prostate tissue. Coagulated depth increased as the laser power became higher. CONCLUSIONS: Laser vaporization of prostate tissue using a high-power laser diode with a wavelength of 980 nm represents a promising treatment for BPH; this method exhibits high vaporization efficiency and good hemostasis. However, operators must be aware of the risk of postoperative perforation of the prostatic capsule caused by coagulation of deep regions that cannot be visualized by endoscopic observation.
Entities:
Keywords:
absorption coefficient; laser surgery; scattering coefficient; transurethral vaporization of the prostate
Authors: Thorsten Bach; Rolf Muschter; Roland Sroka; Stavros Gravas; Andreas Skolarikos; Thomas R W Herrmann; Thomas Bayer; Thomas Knoll; Claude-Clément Abbou; Guenter Janetschek; Alexander Bachmann; Jens J Rassweiler Journal: Eur Urol Date: 2011-10-21 Impact factor: 20.096
Authors: Stavros Gravas; Alexander Bachmann; Oliver Reich; Claus G Roehrborn; Peter J Gilling; Jean De La Rosette Journal: BJU Int Date: 2011-04 Impact factor: 5.588
Authors: Michael Seitz; Oliver Reich; Christian Gratzke; Boris Schlenker; Alexander Karl; Markus Bader; Wael Khoder; Florian Fischer; Christian Stief; Ronald Sroka Journal: Lasers Med Sci Date: 2008-02-13 Impact factor: 3.161
Authors: R Geoghegan; A Santamaria; A Priester; L Zhang; H Wu; W Grundfest; L Marks; S Natarajan Journal: Int J Hyperthermia Date: 2019 Impact factor: 3.914